Home›Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol Tablets

Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol Tablets

Also known as: Lojaimiess

Check Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol Tablets Interactions →
43 interactions on record⛔ Black Box Warning

Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol Tablets has 43 known drug interactions based on U.S. FDA drug labeling data. Of these, 4 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Dasabuvir, Ombitasvir, Paritaprevir. Patients taking Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol Tablets should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total
43
Contraindicated
4
Moderate
33
Minor
2

Contraindicated (4)

Moderate (33)

Minor (2)

Levonorgestrel And Ethinyl Estradiol And Ethinyl Estradiol Tablets + Ritonavir⛔Contraindicated

Human immunodeficiency virus (HIV)/hepatitis C virus (HCV) protease inhibitors and non-nucleoside reverse transcriptase inhibitors: Significant decreases in systemic exposure of the estrogen and/or progestin have been noted when COCs are co-administered with some HIV protease inhibitors (e.g., nelfinavir, ritonavir, darunavir/ritonavir, (fos)amprenavir/ritonavir, lopinavir/ritonavir, and tipranavir/ritonavir), some HCV protease inhibitors (e.g., boceprevir and telaprevir), and some non-nucleoside reverse transcriptase inhibitors (e.g., nevirapine). In contrast, significant increases in systemic exposure of the estrogen and/or progestin have been noted when COCs are co-administered with certain other HIV protease inhibitors (e.g., indinavir and atazanavir/ritonavir) and with other non-nucleoside reverse transcriptase inhibitors (e.g., etravirine). 7.3 Concomitant Use with Hepatitis C Virus (HCV) Combination Therapy – Liver Enzyme Elevation Co-administration of levonorgestrel and ethinyl estradiol tablets and ethinyl estradiol tablets with HCV drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir is contraindicated due to potential for ALT elevations [see Warning and Precautions (5.4) ] .

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.